Cargando…
Intranasal delivery of 9-cis retinoic acid reduces beta-amyloid deposition via inhibiting astrocyte-mediated inflammation
Alzheimer's disease (AD) is associated with the accumulation and deposition of a beta-amyloid (Αβ) peptide in the brain, resulting in increased neuroinflammation and synaptic dysfunction. Intranasal delivery of targeted drugs to the brain represents a noninvasive pathway that bypasses the blood...
Autores principales: | Zhao, Hong, Li, Shuo, Li, Zhuo, Yang, Shuo, Li, Dandan, Zheng, Jiaolin, Gao, Hongmei, Yun, Ling, Gu, YingLi, Li, Longxuan, Zhao, Jing, Fu, Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138573/ https://www.ncbi.nlm.nih.gov/pubmed/32209731 http://dx.doi.org/10.18632/aging.102970 |
Ejemplares similares
-
The critical role of KLF4 in regulating the activation of A1/A2 reactive astrocytes following ischemic stroke
por: Wang, Cong, et al.
Publicado: (2023) -
Intracellular deposits of amyloid-beta influence the ability of human iPSC-derived astrocytes to support neuronal function
por: Konstantinidis, Evangelos, et al.
Publicado: (2023) -
Intranasal Delivery of Collagen-Loaded Neprilysin Clears Beta-Amyloid Plaques in a Transgenic Alzheimer Mouse Model
por: Humpel, Christian
Publicado: (2021) -
Plasma amyloid beta levels are associated with cerebral amyloid and tau deposition
por: Risacher, Shannon L., et al.
Publicado: (2019) -
SIRT1 facilitates amyloid beta peptide degradation by upregulating lysosome number in primary astrocytes
por: Li, Min-Zhe, et al.
Publicado: (2018)